Mehdi Touat

Apr 10, 2024 | inria.hal.science | Thomas Kaley |Mehdi Touat |Institut Gustave Roussy |Vivek Subbiah

Article Dans Une Revue Journal of Clinical Oncology Année : 2018 BRAF Inhibition in BRAF V600 -Mutant Gliomas: Results From the VE-BASKET Study Fichier principal kaley-et-al-2018-braf-inhibition-in-brafv600-mutant-gliomas-results-from-the-ve-basket-study.pdf (793.05 Ko) Télécharger le fichier Origine : Publication financée par une institution Licence : CC BY NC ND - Paternité - Pas d'utilisation commerciale - Pas de modification hal-04541090 , version 1 (10-04-2024) Thomas Kaley, Mehdi Touat,...

Feb 28, 2024 | hal.science | Ingo K. Mellinghoff |Benjamin M. Ellingson |Mehdi Touat |Institut Gustave Roussy

Article Dans Une Revue Journal of Clinical Oncology Année : 2020 Ivosidenib in Isocitrate Dehydrogenase 1 – Mutated Advanced Glioma Fichier principal mellinghoff-et-al-2020-ivosidenib-in-isocitrate-dehydrogenase-1-mutated-advanced-glioma.pdf (1019.09 Ko) Télécharger le fichier Origine : Fichiers éditeurs autorisés sur une archive ouverte Licence : CC BY NC ND - Paternité - Pas d'utilisation commerciale - Pas de modification hal-04481741 , version 1 (28-02-2024) Ingo K Mellinghoff, Benjamin M...

Sep 1, 2023 | medscape.com | Mehdi Touat |Riccardo Soffietti

closePlease confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. There has long been a challenge in the clinical management of diffuse IDH-mutant glioma with no curative therapies and very few treatment options for most patients.

Jun 5, 2023 | medscape.com | Riccardo Soffietti |Mehdi Touat

closePlease confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log outCancel There has long been a challenge in the clinical management of diffuse IDH-mutant glioma with no curative therapies and very few treatment options for most patients.